Year: 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

KUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”) today announced that it...

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

BioNxt Signs Letter Agreement to Acquire 100% Interest in IP and to Codevelop a Sublingual Drug Formulation for Chemotherapy and Immunosuppressant Treatments

VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...

Avandra Acquires DatCard Systems and Sorna Corporation to Create World’s Largest Medical Imaging Platform to Support Patient Care and Breakthrough Medical Research

Avandra expands leading medical imaging platform through dual acquisitions, combining clinical data sharing with research innovationBRECKSVILLE, Ohio, Nov. 30, 2025...

Metrasens Vantage Debuts at RSNA 2025: Intelligent MRI Safety System Delivers Earlier Projectile Risk Detection and Reduced Alarm Fatigue

Revolutionary Zone IV Entry Control System Combines Advanced Ferromagnetic Detection with Intelligent Safety AnalyticsNAPERVILLE, Ill., Nov. 30, 2025 /PRNewswire/ --...

error: Content is protected !!